Article Text


Related Subjects: Kidney and Cardiovascular Disease
e0669 Erythropoietin combined with L-carnitine treatment of renal anaemia on endothelin and left ventricular remodelling
  1. Hui Li,
  2. Shu Sun,
  3. Yumei Wu
  1. Affliated First People's Hospital of Jining of Shandong Academy of Medical Sciences


Objective To observe the effects of Xuezhikang on blood lipids and the levels of plasma endothelins, thromboxane B2, 6-keto-PGFla in patients with primary hyperlipidaemia.

Methods 120 patients with primary hyperlipidaemia were enrolled in this study, 82 males and 38 females, age 36–74 years old, average ages (55±9) years old. 12 weeks after taking Xuezhikang, the clinical effect and the effect on the level of plasma endothelins, thromboxane B2, 6-Keto-PGFla were compared before and after the treatment, and the relation between blood lipids and ratio of plasma endothelins, thromboxane B2 to 6-Keto-PGFla were analysed.

Results 12 weeks after treatment, the level of TG, cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and apoB100 decreased sharply (p<0.05–0.001); the level of serum high density lipoprotein cholesterol (HDL-C) elevated (p<0.05); ratio of plasma endothelins decreased sharply (p<0.001); rate value of thromboxane B2 to 6-Keto-PGFla before treatment was higher than health people but lower after treatment (p<0.01). There were positive correlations between the decreased TC. TG, LDL-C and decreased ET-1, the ratio TXB2/6-keto-PGFla (r=0.832–0.963, p<0.01–0.001). The same positive correlation was found between the decreased ET-1 and the ratio of TXB2/6-keto-PGF1a (r=0.987, p<0.001).

Conclusions Plasma endothelins level and ratio of thromboxane B2 to 6-Keto-PGFla increased in the patients with primary hyperlipidaemia. Xuezhikang not only effectively adjusted blood lipids level but also reduced plasma endothelins level and ratio of thromboxane B2 to 6-Keto-PGFla.

  • Cholesterol (TC)
  • low density lipoprotein cholesterol (LDL-C)
  • high density lipoprotein cholesterol (HDL-C)
  • TG

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.